Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
National Institutes of Health
About this archived opportunity
The purpose of this notice of funding opportunity (NOFO) is to support translational and clinical research to (1) advance precision medicine in pregnant women, lactating women, and children through the development of novel tools, models, and other technologies that could have a direct clinical or health impact; (2) enhance the understanding of the underlying mechanisms of drug action, including the role of pediatric ontogeny and the dynamic physiological changes that occur during pregnancy and lactation; and (3) discover and develop novel therapeutics or enhance the usage of existing drugs or drug repurposing for safer and more effective medications in pregnant and lactating women, neonates, and children. The overall goal is to improve safe and effective precision therapeutics for pregnant and lactating women, fetuses, neonates, and children, including those with disabilities.
Historical details
- Status
- Closed
- Deadline
- July 6, 2026
- First captured
- December 17, 2025
- Publisher reference
- 357185
Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
This opportunity has closed
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
by National Institutes of Health
Get notified when similar opportunities open
We'll save this search and email you when new translational, research, maternal opportunities are posted. Free.
Related opportunities
- Translational Neural Devices (R61/R33 - Clinical Trial Optional)National Institutes of HealthCloses Jan 2027
- Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)National Institutes of HealthCloses Jan 2028Up to $499K
- Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional)National Institutes of HealthCloses Nov 2027Up to $6.3M
- NIDCD Research Grants for Translating Basic Research into Clinical Practice (R01 Clinical Trial Optional)National Institutes of HealthCloses Oct 2027Up to $500K
- Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)National Institutes of HealthCloses Jan 2028Up to $499K
- Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)National Institutes of HealthCloses Nov 2028Up to $400K